ALIZEA™

Connected, yet free

Healthcare Professionals Cardiac Rhythm Management Cardiac Rhythm Management Products Pacemakers ALIZEA™

ALIZEA™

Connected, yet free

The world around us is changing faster than ever before. There has never been a greater need for innovative ways to stay connected and free up more time.

  • Promote physiological pathways
  • Maintain excellent clinical follow-ups remotely
  • Excellent longevity* in remote mode reduces the need for replacements1
  • Efficiently manage AF while improving clinical outcomes.
Watch the video
ALIZEA™ Alizea Transparent 1

PROMOTE PHYSIOLOGICAL PATHWAYS

  • LBBAP:
    • Alizea™ is approved for Left Bundle Branch Area Pacing, ensuring physiological pacing10
    • MR conditional mixed system supporting LBBAP leads11
    • LBBAP information visible at a glance on programmer
  • SafeR™ – by preserving natural AV conduction, minimizes ventricular pacing for SND and AVB patients3,4
  • Dual Sensor – Designed to physiologically modulate heart rhythm by combining accelerometer and minute ventilation sensors
Explore SafeR™
ALIZEA™ 2 Alizea visual 1

WORLD’S FIRST MR CONDITIONAL MIXED SYSTEM11

Redefining boundaries for MRI conditionality

ALIZEA™ pacemaker, when implanted in combination with selected third-party MR conditional lead(s), constitutes a FULL BODY MR CONDITIONAL PACING SYSTEM11

  • FLEXIBILITY:
    • Expand compatible leads selection
    • Expand MRI benefits to more patients
  • SAFETY:
    • Rigorously tested and approved for enhanced confidence
  • LBBAP:
    • MR conditional system supporting LBBAP leads
  • EXCELLENCE:
    • Same outstanding ALIZEA™ features
    • More MRI leads compatible
ALIZEA™ MICROPORT Mixed System ALIZEA pour GIF 2

ALIZEA BLUETOOTH ENABLED PACEMAKERS - TESTIMONIALS

There are more and more patients in need of pacemaker implantations. When doctors’ time and resources are limited, this causes an issue when it comes to patient follow-ups.

That’s why the cardiologists at the University Hospital of Gran Canaria Dr Negrin have chosen MicroPort’s Alizea pacemakers equipped with Bluetooth® technology to make patient follow-up remote, combined with SafeR® algorithms and excellent longevity.
Hear their testimonials now!

MAINTAIN EXCELLENT CLINICAL FOLLOW-UP –REMOTELY

AlizeaTM comes with SmartView ConnectTM, an innovative Bluetooth® remote monitoring system that offers advanced patient monitoring and follow-up, providing timely alerts and detailed reports of your patient.

CUSTOMIZABLE ALERTS FOR ADDED RELEVANCE

  • Clinical notifications help you keep track of your patient’s clinical status
  • System alerts oversee the system integrity and ensure the pacemaker’s continuous function.
  • Lead alerts indicate potential dislodgement or lead fracture
  • Notifications of post-MRI device function
ALIZEA™ Smartview connect screens 1

Intelligent clinical data retrieved remotely

Quick assessment of the device status with a traffic light system

Overview of relevant clinical data on:

  • Atrial fibrillation
  • Sleep apnea**
  • AV conduction
ALIZEA™ Alizea patient report p1 2

13 YEARS2 LONGEVITY

with remote monitoring and full feature set ON, including:

  • Up to 22 mins of EGM with pre-event EGM recordings
  • Continuous sleep apnea monitoring**
  • MV and G sensors for optimal rate adaptation

Thanks to an excellent longevity3 with remote monitoring, you can provide continuous and efficient patient care.

ALIZEA™ Alizea3 3

EFFICIENTLY MANAGE AF WHILE IMPROVING CLINICAL OUTCOMES4,5

Alizea has a unique combination of features that work together to help improve patient outcomes

  • Accurately detects AF
    Warad accurately detects AF even in cases of undersensing.6
  • Prevents onset of AF
    SafeR is clinically proven to prevent first onset of AF4,5, through reducing unnecessary ventricular pacing.7
  • Reveals the silent cause of AF
    Sleep apnea monitoring** (SAM) helps you to detect and monitor a frequent cause of AF.8
ALIZEA™ Alizea brochure p10 jpg 4

MORE INDEPENDENCE WITH AutoMRI™

AutoMRI™ offers flexibility in scheduling MRI scans, enabling advanced care for your patients and allowing more independence for cardiologists, radiologists and patients.

Visit.
The cardiologist will turn AutoMRI™ ON up to 10 days before a patient’s MRI scan.

Scan.
As your patient enters the MRI scan room, the device automatically switches into asynchronous MRI mode. Moving away from the scanner, 5 minutes after your patient leaves, the device switches back to the initial settings.

Go.
Your patient is free to leave without any cardiologist intervention.9

ALIZEA™ Alizea2 5
Safer

SafeR™

Dramatically reduces unnecessary RV pacing in all pacemaker patients, including AV block patients.

Discover this therapy
SAM

SAM™

Sleep Apnea Monitoring** measures respiration pauses and reduction in respiration.

Discover this therapy
Logo Auto MRI circle blue

AutoMRI™

Making MRI scans easy and safe for pacemaker patients.

Discover this feature
Dual

Dual Sensor™

Designed to physiologically modulate heart rhythm by combining Accelerometer and Minute Ventilation sensors.

Discover this therapy

*13 years with SafeR™ mode, assuming 5% V pacing and 50% A pacing, 60 min-1, 2.5 V, 0.35 ms, 750 Ohms, Holter ON, sensors ON, Remote ON

** Sleep Apnea Monitoring is not available in the USA
 

REFERENCES

  1. Boriani G, Bertini M, Saporito D, et al. Impact of pacemaker longevity on expected device replacement rates: Results from computer simulations based on a multicenter registry (ESSENTIAL). Clin Cardiol. 2018;41(9):1185‐1191. doi:10.1002/clc.23003
  2. SafeR™ mode, assuming 5% V pacing and 50% A pacing, 60 min-1, 2.5 V, 0.35 ms, 750 Ohms, Holter ON, sensors ON, Remote ON
  3. Versus previous pacemaker generation (Eno).
  4. Boveda S, Defaye P, Moreno J et al. Minimized ventricular pacing to prevent the first onset of AF in pacemaker patients without atrial arrhythmia history: results from the ANSWER study, Euro-pace Abstracts 17(Suppl 3):iii24,2015
  5. Fauchier L, Moreno J, Defaye P, Stockburger M. SafeR is associated with a risk reduction of first-onset AF in patients with atrioventricular blocks: results from the ANSWER study. Europace 8(suppl 1):i170, 2016
  6. Bonnet JL, Brusseau E, Limousin M, Cazeau S. Mode switch despite undersensing of atrial fibrillation in DDD pacing. PACE 19: 1724–1728, 1996
  7. Stockburger M. et al. Safety and efficiency of ventricular pacing prevention with an AAI-DDD changeover mode in patients with sinus node disease or atrioventricular block: impact on battery longevity-a sub-study of the ANSWER trial; Europace. 2016 May; 18(5): 739–746
  8. Linz D et al. Variability of Sleep Apnea Severity and Risk of Atrial Fibrillation: The VARIOSA-AF Study. JACC Clin Electrophysiol. 2019 Jun;5(6):692-701. doi: 10.1016/j. jacep.2019.03.005. Epub 2019 May 1.
  9. MicroPort® CRM MRI Solutions Manuals available online at microportmanuals.com.
  10. Alizea™ User Manual available online at microportmanuals.com
  11. System consisting of a pacemaker and one or more lead(s). Refer to MRI solutions for complete information available online at microportmanuals.com